Creative Studio Powster Announces Innovation for Movie Studios
Movie studios can now sell movie theater tickets on their official movie websites. Cinemagoers can now buy tickets directly on websites such as www.deadpool.com, www.adrift.movie, www.equalizer.movie, and the upcoming site for Mission: Impossible - Fallout. These ticketing portals are activated across all social media, meaning studios can now sell their own tickets from their Facebook, Twitter, Instagram and other social media channels.
Powster creates movie websites for all six major studios and launches over 170 sites every month. After successful Beta testing, Powster has now enabled full ticketing on these movie websites so that cinemagoers can complete the entire purchasing journey without redirecting the user to a third-party website.
Powster’s ability to launch full-ticketing at scale is in part related to movieXchange’s MX Tickets service, Vista Group’s new global ticketing platform allowing ticket sellers to integrate with and transact against all exhibitors. By integrating the full payment process into the movie site, Powster has improved the user journey of purchasing a ticket letting users purchase directly on the movie website, making going to the cinema easier than ever.
The Powster ticketing model is unique to the industry. Payments are deposited directly with the theater, eliminating the administrative hang-ups previously associated with third-party ticket sales. For studios, Powster ticketing ensures visibility and measurement of the entire purchasing process culminating in actual ticket sales.
Hollywood distributors and industry partners Twentieth Century Fox Film, Paramount Pictures, STXfilms, RealD, Annapurna, The Orchard, CBS Films, Magnolia Pictures, Amazon Studios, ShortsTV, FilmRise, GKIDS, Gunpowder & Sky, and more have partnered with Powster and integrated full ticketing flow into their systems.
Powster CEO Ste Thompson says, “We have researched into the best solution for both movie theaters and movie distributors. Our solution equally benefits both parties by enabling the movie studio to optimise their advertising and the movie theater to retain the customer.”
Over 20 theaters have signed on to implement Full Ticketing upon its release. B+B Theatres, New Vision Cinemas, Celebration Theatres, Starlight Cinemas, Paramount 5, D’Place Entertainment, Envision Cinemas Bar & Grille, Main Street Theatres, Midwest Movies, FatCats Entertainment, and Tristone Cinemas are early adopters of the new system. Full Ticketing will reach over 27,000 screens in its first month(s) of processing.
Powster ticketing can be integrated into social platforms, such as Facebook, Snapchat, and Instagram, so users can complete their ticket purchase without leaving the site. Full ticketing has also been built into Powster’s Facebook Messenger experiences, where users can set reminders, watch movie trailers, and organize showtimes with friends all without leaving Messenger.
Powster will be exhibiting Full Ticketing, AR capabilities, and Messenger integration at CineEurope, in the main foyer, across from the trade show registration booth. If you would like to arrange a chat in advance, please email PR and Marketing Coordinator Samantha Robinson - firstname.lastname@example.org.
POWSTER, part of the Vista Group of companies (NZX: VGL) (ASX: VGL), is a creative and innovation studio operating in London and Los Angeles. The business provides creative services to the film and music industry and creates products to help engage users with entertainment content. The global leader in film distribution marketing websites, POWSTER creates more than 170 destinations a month for 100+ movie distributors in over 40 countries. The POWSTER movie platform enables over thirty-five million cinemagoers a month to discover showtimes on official movie websites.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
American Express Wins Major Antitrust Lawsuit25.6.2018 18:05 | Pressemelding
American Express (NYSE:AXP) issued the following statement today from Chairman and CEO Stephen J. Squeri regarding the U.S. Supreme Court’s decision in the Department of Justice’s antitrust lawsuit: “The Court’s decision is a major victory for consumers and for American Express. “This was a long battle, but well worth the fight because important issues were at stake: consumer choice, fair market competition, and the ability to deliver innovative products and services to our customers, both consumers and merchants. “As the Supreme Court stated today, ‘…Amex’s business model has stimulated competitive innovations in the credit-card market, increasing the volume of transactions and improving the quality of the services.’ “Since this case started eight years ago, we have significantly expanded the network of merchants who willingly accept American Express, and have seen merchant satisfaction steadily increase. We have also broadened the range of benefits, services and experiences that buil
Synteract Announces Collaboration with International Children’s Advisory Network iCAN Research25.6.2018 17:03 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full, phase I-IV services enabling drug development companies to bring new medicines to market, has signed a memo of understanding to partner with the International Children’s Advisory Network (iCAN). A worldwide consortium of children’s advisory groups, iCAN is dedicated to giving children and families a voice in health, medicine, research, and innovation by increasing education about the importance of children’s involvement. Synteract is a sponsor at the 2018 iCAN Research Summit in Edinburgh, Scotland, UK, July 8-13, 2018 and will hold two interactive plenary seminar sessions at the event. With chapters across the U.S. and worldwide, iCAN partners with local children’s hospitals and addresses the needs of pediatric clinical research and healthcare and advocates for patients worldwide. In partnering with iCAN, Synteract will expand its access to children and families familiar with clinical research. iCAN will sup
GA-ASI to Fly First Trans-Atlantic Flight of a MALE RPA25.6.2018 16:55 | Pressemelding
On July 10-11, General Atomics Aeronautical Systems, Inc. (GA-ASI) plans to make the first-ever trans-Atlantic flight of a Medium-altitude, Long-endurance (MALE) Remotely Piloted Aircraft (RPA). GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static display July 13-15 for the Royal International Air Tattoo (RIAT) airshow being held at RAF Fairford. The flight and display will commemorate the RAF’s centenary celebration (RAF100). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005946/en/ GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static displa
Quadient Announces General Availability of Quadient Inspire R1225.6.2018 14:30 | Pressemelding
www.quadient.com : Quadient, the award-winning leader in Customer Communications Management (CCM), announced the general availability of its newest release, Quadient Inspire R12, which includes the new Digital Advantage Suite. The updated version of Quadient Inspire is designed to give customers and partners greater control over the systems and processes used to drive consistent communications across all channels with an emphasis on digital experiences. With Inspire R12, users design omni-channel communications in days rather than months with a simple, modern and comprehensive platform. The solution makes it possible to change designs and test for all channels in minutes, with fully integrated tracking and approval processes built in. Additionally, R12 integrates all parts of the communications process from linking journey maps to communications, postal sorting, address, phone and email verifications, email delivery, SMS delivery, mail delivery tracking, and production monitoring to re
The Dementia Discovery Fund Raises $350 Million25.6.2018 13:00 | Pressemelding
The Dementia Discovery Fund (DDF) today announces the completion of its fundraising, with £250 million ($350 million at the time of completion) raised from an influential group of strategic investors committed to developing new medicines for dementia. The goal was met today with a new investment of $60 million from US AARP, the global nonpartisan organisation dedicated to empowering Americans 50 and older to choose how they live as they age. The fundraising far exceeded its initial target of $200 million (£130 million), making it the first and largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease. The DDF makes early stage venture capital investments to develop novel disease-modifying therapeutics for all forms of dementia. The fund is managed by SV Health and was formed through the collaboration of leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and
Professor Thierry Philip Takes Office as OECI President25.6.2018 12:22 | Pressemelding
Professor Thierry Philip, President of the Institut Curie, has been elected President of the Organisation of European Cancer Institutes ( OECI ) for a three-year term. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005600/en/ Pr Thierry Philip (Photo: Business Wire) At the end of June 2018, Professor Philip, an oncologist and pediatrician, will take over as head of this European organization, which brings together 90 institutes and university centers and whose mission is fully devoted to cancer. This European non-governmental, non-profit organization aims to promote cooperation between its members or associate members and pursues a triple objective: to provide cancer patients in Europe with equal access to high-quality care; to assist European institutes with the implementation of a quality system for oncology care; to promote and accelerate the progress of translational research. In this regard, half of the 90 OECI ce